Forensic Analysis · Semiconductors · as of Aug 11, 2026
Synaptics Inc (SYNA)
A forensic read on Synaptics Inc built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
D · Weak — demands caution
Forensic grade
Safe
Financial health
6.1
Distress distance
Clean
Earnings quality
3
Forensic signals
-8.4
P / E (ttm)
-3.4%
ROE
$4.1B
Market cap
0.00%
Dividend yield
12.0%
Revenue growth
This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (red flags, auditor quality, say on pay, board independence). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.
Synaptics Inc earns a D (Weak — demands caution) forensic quality grade, and its balance-sheet distress test reads 6.1, placing it in the Safe zone. 3 forensic signals were flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
-3.9%
FY2025
Return on invested capital.Return on invested capital is -3.9% in the latest fiscal year and slipping from 18% — well below its ~10% cost of capital, so reinvested dollars may be destroying value, not building it.
110% of FCF
FY2025
Shareholder returns.Returned $128M to shareholders (buybacks + dividends) in FY2025 — 110% of free cash flow. More than free cash flow generated — and beyond operating cash too, so the extra is coming from debt or cash reserves, which isn't sustainable indefinitely. Counting the $113M of stock-based comp paid out in shares on top of that, the combined claim on free cash flow is 207%.
+16.2%
FY2024→FY2025
Accruals ratio (% of NOA).Net operating assets grew +16.2% relative to their own average in FY2025 — scaled by NOA itself, not total assets (see the Forensic Screens card's differently-scaled Sloan Accrual Ratio for that read). Accruals are building faster than is comfortable — part of profit is sitting in the balance sheet rather than turning to cash. The build is led by inventory up +22% against +14% in cost of sales. The cash-flow cross-check is more mixed: reported earnings ran behind operating cash by 11% of net operating assets, diverging from the balance-sheet accrual read.
Key fundamentals
Latest Revenue$1.07B
Revenue Growth YoY+12.0%
Net Margin-4.4%
Free Cash Flow$116.2M
Return on Equity-3.4%
Debt / Equity0.60x
The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Synaptics Inc's actual 10-K/10-Q/8-K filings?